Skip to main content
Medeniyet Medical Journal logoLink to Medeniyet Medical Journal
. 2026 Jun 30;41(2):219–229. doi: 10.4274/MMJ.galenos.2026.76570

Multimodal Pain Management in Emergency Medicine: A Narrative Review

Acil Tıpta Multimodal Ağrı Yönetimi: Bir Derleme

Behcet AL 1,✉, Fatih TURKMEN 1
PMCID: PMC13320404  PMID: 42383452

ABSTRACT

Pain is one of the most common reasons for presentation to the emergency department, yet it remains frequently undertreated despite effective therapies. Emergency physicians must provide timely analgesia while accounting for diagnostic uncertainty, patient heterogeneity, and safety concerns, particularly related to opioid use.

This narrative review synthesizes contemporary evidence on multimodal pain management in emergency medicine. A focused literature search of PubMed and Scopus was conducted to identify studies published between 2015 and 2025, as well as selected landmark studies and major clinical guidelines. Multimodal analgesia, combining pharmacological and non-pharmacological strategies targeting different pain pathways, is associated with improved pain control and reduced opioid use in emergency settings. Key elements include early pain assessment, timely initiation of therapy, opioid-sparing approaches, and use of non-opioid analgesics, low-dose ketamine, and regional anesthesia. Implementation remains inconsistent due to operational constraints such as overcrowding, workflow pressures, and variability in clinician experience.

A structured, patient-centered multimodal approach may improve pain control and support safer, more consistent analgesic care in emergency medicine.

Keywords: Multimodal analgesia, emergency medicine, acute pain, ketamine, regional anesthesia

INTRODUCTION

Pain represents one of the most common reasons for presentation to the emergency department (ED) worldwide and represents a fundamental component of emergency care1, 2. Despite its high prevalence, pain management in the ED remains inconsistent and frequently suboptimal, reflecting a persistent gap between available evidence and clinical practice3, 4.

The undertreatment of pain, commonly referred to as oligoanalgesia, is a multifactorial problem involving patient-, clinician-, and system-level factors1, 5. Clinicians may delay analgesia because of concerns about masking diagnostic findings, particularly in conditions such as abdominal pain. However, current evidence suggests that early analgesia does not generally compromise diagnostic accuracy when accompanied by appropriate clinical reassessment and documentation6, 7. System-level challenges—including ED overcrowding, high patient turnover, and workflow interruptions—further contribute to delays in pain management8, 9. In addition, concerns regarding opioid-related harms and prescribing practices have influenced pain management strategies in many healthcare systems, although the epidemiology and clinical impact of opioid use vary substantially across countries and regions10, 11.

Patient-related factors, including age, comorbidities, prior opioid exposure, and communication barriers, significantly influence pain perception and treatment response. Disparities related to demographic characteristics, including age, gender, and ethnicity, further highlight the complexity of achieving equitable and effective pain management12, 13.

Multimodal analgesia has emerged as an effective and evidence-based approach to addressing these challenges. By combining pharmacological and non-pharmacological interventions targeting different mechanisms of pain processing, multimodal strategies enhance analgesic efficacy while reducing opioid requirements and associated risks14, 15. Advances in analgesic pharmacology, increasing use of low-dose ketamine, and the expanding role of ultrasound-guided regional anesthesia have broadened the therapeutic options available to emergency physicians16, 17.

Despite these advances, implementation remains inconsistent across EDs, largely due to variability in clinician experience, lack of standardized protocols, and limited training opportunities18, 19.

Despite increasing interest in multimodal analgesia, there remains a need for a clinically oriented synthesis that integrates current evidence with practical decision-making in emergency settings. This narrative review aims to provide a clinically focused synthesis of multimodal pain management in emergency medicine, with particular emphasis on evidence-based strategies, practical applications, and real-world implementation challenges. This review aims to provide a clinically applicable, ED-oriented decision framework that integrates opioid-sparing multimodal analgesia, scenario-based analgesic selection, regional anesthesia considerations, and implementation challenges.

MATERIALS and METHODS

This study was designed as a narrative review aimed at providing a clinically focused synthesis of multimodal pain management strategies in emergency medicine.

A literature search was conducted using the PubMed and Scopus databases to identify relevant studies and clinical guidelines on acute pain management in ED settings. Search terms included combinations of “ED,” “acute pain,” “pain management,” “multimodal analgesia,” “ketamine,” “opioids,” “regional anesthesia,” and “opioid-sparing strategies.” The literature search was conducted from January to February 2025. The search strategy included combinations of the following keywords and Medical Subject Headings terms: “ED,” “acute pain,” “pain management,” “multimodal analgesia,” “opioids,” “ketamine,” “regional anesthesia,” “nerve block,” and “opioid-sparing analgesia.”

The review primarily focused on studies published between January 2015 and January 2025 to emphasize contemporary evidence and current emergency medicine practice. However, selected landmark studies and historically important references published before 2015 were also included when they were considered clinically or conceptually relevant.

Eligible sources included randomized controlled trials, observational studies, systematic reviews, meta-analyses, narrative reviews, and major international clinical practice guidelines. Guidelines and consensus statements from organizations such as the American College of Emergency Physicians, the National Institute for Health and Care Excellence, and the World Health Organization were specifically reviewed to ensure consistency with current standards of care18, 19, 20.

Studies were selected based on their relevance to emergency medicine practice, clinical applicability, methodological quality, and contribution to multimodal pain management concepts. Articles not directly related to emergency care, non-English publications, conference abstracts without sufficient methodological detail, and studies with limited clinical applicability were generally excluded.

As this review was narrative and non-systematic, a formal PRISMA-guided screening process, a risk-of-bias assessment, and a quantitative meta-analysis were not performed. The aim of this approach was to provide a clinically practical and concept-oriented synthesis of the literature relevant to ED pain management.

Because this study was designed as a narrative review rather than a formal systematic review, the literature selection process was intentionally pragmatic and clinically oriented. PubMed and Scopus searches were conducted using combinations of the terms “ED,” “acute pain,” “pain management,” “multimodal analgesia,” “opioids,” “ketamine,” “regional anesthesia,” “nerve block,” and “opioid-sparing analgesia.” Search combinations were iteratively refined to identify clinically relevant studies, major guidelines, and landmark publications applicable to ED practice. A summary of the literature identification and selection process is presented in Figure 1.

Figure 1.

Figure 1

Simplified literature selection process for the narrative review.

Pain Physiology and Clinical Implications

Pain in the emergency setting is a complex and multidimensional experience involving nociceptive, neuropathic, and mixed mechanisms21. From a clinical perspective, understanding these mechanisms is critical, as different analgesic agents target distinct pathways and therefore influence treatment decisions.

Nociceptive pain arises from tissue injury and activation of peripheral nociceptors. It is the most common type encountered in the ED and typically associated with trauma, fractures, and inflammatory conditions. This type of pain is generally responsive to non-opioid analgesics such as non-steroidal anti-inflammatory drugs (NSAIDs) and paracetamol14, 22.

Neuropathic pain, in contrast, results from injury or dysfunction of the nervous system and is often described as burning, shooting, or electric. It is less responsive to conventional analgesics and may require alternative strategies such as ketamine or adjuvant therapies4, 16.

Mixed pain syndromes are frequently observed in emergency settings, particularly in severe trauma and oncological conditions. These cases require a multimodal approach because they involve multiple pain pathways23.

Pain Assessment in the ED

Accurate and timely pain assessment is the foundation of effective pain management. The most commonly used tools in emergency practice include the numeric rating scale (NRS), visual analog scale, and Wong-Baker FACES Scale24.

However, pain assessment in the ED is inherently challenging due to several factors:

Cognitive impairment, particularly in elderly patients

• Language and communication barriers

• Cultural differences in pain expression

• Time pressure and overcrowding

These challenges frequently lead to under-documentation and delayed analgesia5, 25.

A key concept in modern emergency care is that pain assessment should be dynamic rather than static. Initial assessment must be followed by reassessment after intervention, allowing clinicians to titrate therapy based on response6.

Another important aspect is the integration of pain assessment into triage systems. Early identification of severe pain allows for timely initiation of analgesia, which has been shown to improve patient satisfaction and clinical outcomes8.

Pharmacological Strategies in Multimodal Analgesia

Pharmacological management represents the core component of multimodal pain control in the ED. The goal is not merely to relieve pain, but to do so rapidly, safely, and with minimal adverse effects, while maintaining diagnostic clarity.

Non-Opioid Analgesics

a. Paracetamol (Acetaminophen)

Paracetamol is widely used as a first-line agent due to its favorable safety profile and broad applicability. It is effective in mild-to-moderate pain and serves as a key component of multimodal regimens26.

Intravenous administration offers a faster onset of action and is particularly useful for patients who are unable to tolerate oral medications.

b. NSAIDs

NSAIDs are highly effective in inflammatory pain conditions such as renal colic, musculoskeletal injuries, and soft tissue trauma22.

They exert their effects through inhibition of cyclooxygenase enzymes, thereby reducing prostaglandin synthesis.

However, their use requires careful consideration in:

• Renal impairment

• Gastrointestinal bleeding risk

• Cardiovascular disease

Despite these limitations, NSAIDs remain a cornerstone of ED pain management and are frequently used in combination with paracetamol to enhance analgesic efficacy27, 28.

Opioids

Opioids remain essential for the management of moderate-to-severe pain in the emergency setting.

Common agents and clinical considerations:

• Morphine: Typically administered intravenously in titrated doses (0.05-0.1 mg/kg), allowing for controlled analgesia and reassessment.

• Fentanyl’s rapid onset and shorter duration make it particularly useful in acute settings and for procedural analgesia.

The key principles of opioid use in the ED include:

• Titration rather than bolus dosing

• Frequent reassessment

• Monitoring for respiratory depression and sedation

While concerns regarding opioid misuse are valid, evidence suggests that appropriate, short-term use in the ED is safe and effective when guided by clinical judgment10, 11.

Ketamine

Ketamine has emerged as one of the most important agents in modern multimodal analgesia.

Low-dose (sub-dissociative) ketamine:

• Dose: 0.1-0.3 mg/kg IV

Advantages:

• Rapid onset of analgesia

• Opioid-sparing effect

• Minimal respiratory depression

Ketamine is particularly valuable in:

• Trauma patients

• Opioid-tolerant individuals

• Patients with hypotension for whom opioids may be less desirable16, 29.

Emerging evidence supports its use both as a primary analgesic and as an adjunct to opioids30.

Methoxyflurane

Methoxyflurane is an inhaled analgesic that provides rapid and patient-controlled pain relief.

It is particularly useful in trauma settings and prehospital care, offering ease of administration without requiring intravenous access31, 32.

However, the availability, regulatory approval, and routine clinical use of methoxyflurane vary substantially across countries and healthcare systems, and its use should therefore be interpreted within the context of local practice and institutional policies.

The comparative onset and duration profiles of commonly used ED analgesics are summarized in Table 1.

Table 1. Comparative characteristics of common analgesics used in the emergency department.

Analgesic

Typical ED dose

Approximate onset

Approximate duration

Key considerations

Paracetamol

1 g IV/PO

30-60 min

4-6 h

Hepatic dose limits

NSAIDs

Agent-specific

20-60 min

4-8 h

Renal/GI/cardiovascular risk

Morphine

0.05-0.1 mg/kg IV (titrated)

5-10 min

3-4 h

Respiratory/sedation monitoring

Fentanyl

0.5-1 mcg/kg IV

1-3 min

30-60 min

Rapid reassessment needed

Ketamine (low-dose)

0.1-0.3 mg/kg IV

1-5 min

30-60 min

Psychoperceptual effects

Methoxyflurane

Inhaled (where available)

5-10 min

20-30 min

Availability varies

NSAID: Non-steroidal anti-inflammatory drug, h: Hour, min: Minute

Multimodal Analgesia Strategies in Emergency Medicine

Multimodal analgesia represents the integration of multiple pharmacological and non-pharmacological interventions targeting different pain pathways. In emergency medicine, this approach is particularly valuable due to the need for rapid, effective, and safe pain control.

Rather than relying on a single agent, multimodal strategies combine drugs with complementary mechanisms of action, thereby enhancing analgesic efficacy while reducing dose-dependent adverse effects15, 33.

Rationale for Multimodal Approaches

The physiological basis of multimodal analgesia lies in the complex nature of pain processing, which involves peripheral transduction, spinal transmission, and central perception22. Targeting only one pathway is often insufficient, particularly in moderate-to-severe pain.

For example:

● NSAIDs reduce peripheral inflammation

● Opioids modulate central pain perception

● Ketamine acts on N-methyl-D-aspartate (NMDA) receptors, reducing central sensitization

Combining these agents allows for synergistic effects and improved outcomes15, 30.

Practical Multimodal Combinations

Mild Pain

● Paracetamol + NSAID → Effective for musculoskeletal injuries and minor trauma27.

Moderate Pain

● Paracetamol + NSAID + low-dose opioid → Provides balanced analgesia with reduced opioid exposure28.

Severe Pain

● Opioid + ketamine ± regional anesthesia → Particularly effective in trauma and opioid-tolerant patients16, 29.

Opioid-Sparing Strategies

● Ketamine + non-opioid analgesics → reduces opioid requirements while maintaining analgesic efficacy30.

Common scenario-based multimodal analgesic combinations used in emergency practice are presented in Table 2.

Table 2. Common multimodal analgesic combinations in emergency practice.

Clinical scenario

Recommended combination

Rationale

Mild pain

Paracetamol + NSAID

Additive/synergistic analgesia

Moderate pain

Paracetamol + NSAID + opioid

Balanced analgesia

Severe trauma

Opioid + ketamine

Rapid, strong analgesia

Hip fracture

Regional block + paracetamol ± opioid

Opioid-sparing

Opioid-tolerant patient

Ketamine-based regimen

Avoids escalation

Hip fracture

Regional block + paracetamol ± opioid

Opioid-sparing

NSAID: Non-steroidal anti-inflammatory drug

Analgesic selection should be individualized based on patient age, comorbidities, renal function, pregnancy status, opioid tolerance, and local clinical expertise.

Timing and Sequencing

An important but often overlooked aspect of multimodal analgesia is timing.

● Early administration improves outcomes

● Sequential escalation allows safer titration

● Simultaneous initiation may be appropriate in severe pain

Delayed analgesia is associated with worse outcomes and decreased patient satisfaction8.

Regional Anesthesia in Emergency Medicine

Regional anesthesia has become an increasingly important component of multimodal pain management in emergency medicine. With the widespread adoption of point-of-care ultrasound (POCUS), emergency physicians can now perform targeted nerve blocks safely and effectively, often achieving superior analgesia compared with systemic medications17, 34. Nevertheless, regional anesthesia techniques require careful consideration of contraindications and procedural precautions, including anticoagulation status, infection at the injection site, risk of compartment syndrome, operator competency, local anesthetic allergy, potential nerve injury, and the risk of local anesthetic systemic toxicity.

Clinical Advantages

Regional anesthesia offers several key benefits:

● Superior analgesic efficacy compared to systemic opioids

● Opioid-sparing effect, reducing the risk of respiratory depression

● Improved functional outcomes, particularly in orthopedic injuries

● Reduced delirium risk, especially in elderly patients

These advantages make regional techniques particularly valuable in high-risk populations35.

Commonly Used Blocks in the ED

Femoral Nerve Block

Widely used in femoral fractures and hip injuries. Provides rapid and effective analgesia.

Fascia Iliaca Block

A safer and technically simpler alternative, especially suitable for ED settings. Demonstrates significant opioid-sparing effects in hip fracture patients36.

Upper Extremity Blocks

Used in shoulder dislocations and forearm injuries.

Implementation Challenges

Despite strong evidence, regional anesthesia remains underutilized in many EDs due to:

● Limited training opportunities

● Time constraints

● Lack of standardized protocols

Addressing these barriers requires structured education and institutional support18.

Clinical Scenarios and Practical Applications

A key strength of multimodal analgesia lies in its adaptability to specific clinical scenarios. Emergency physicians must tailor analgesic strategies based on the underlying condition, patient characteristics, and clinical context.

Trauma Pain

Trauma patients often present with severe pain requiring rapid intervention.

Recommended Approach

● Opioid (titrated) + ketamine

● Early consideration of regional anesthesia

Ketamine is particularly advantageous due to its hemodynamic stability and opioid-sparing effect16.

However, treatment selection should remain individualized, taking into account hemodynamic status, associated injuries, contraindications, and clinician experience.

Renal Colic

Renal colic is a classic example of inflammatory pain.

First-line Treatment

● NSAIDs

These agents reduce prostaglandin-mediated ureteral spasm and are often more effective than opioids in this context22. NSAID use should be carefully considered in patients with renal impairment, at risk of gastrointestinal bleeding, receiving anticoagulants, or who are pregnant.

Headache

Opioids should generally be avoided in primary headache disorders such as migraine because of the risk of medication-overuse headache and poorer long-term outcomes, although the individual clinical context and the secondary headache etiologies should also be considered.

Preferred Strategy

● NSAIDs

● Antiemetics

● Adjunctive therapies

Evidence suggests that non-opioid regimens are more effective and associated with fewer adverse outcomes37.

Abdominal Pain

Historically, analgesia was delayed due to diagnostic concerns. However, current evidence suggests that early analgesia does not generally compromise diagnostic accuracy when accompanied by appropriate clinical reassessment and documentation6, 7.

Hip Fracture in Elderly Patients

This represents a high-risk population.

Optimal Strategy

● Fascia iliaca block + paracetamol ± opioid

This approach reduces delirium and improves outcomes35, 36. Regional anesthesia should be performed with attention to anticoagulation status, local infection risk, cognitive status, and institutional expertise.

Scenario-based analgesic strategies for common emergency presentations are summarized in Table 3.

Table 3. Scenario-based multimodal analgesia in the emergency department.

Clinical scenario

Preferred strategy

Key considerations

Trauma

Opioid + ketamine ± block

Rapid, severe pain

Renal colic

NSAID ± opioid

Inflammatory mechanism

Headache

Non-opioid regimen

Avoid opioids

Abdominal pain

Early multimodal analgesia

No diagnostic delay

Hip fracture

Regional block + multimodal

Elderly, high risk

Recommended strategies should be interpreted within the context of patient-specific contraindications, hemodynamic status, medication history, and institutional resources.

NSAID: Non-steroidal anti-inflammatory drug.

Risk Management and Patient Safety

Effective pain management must balance analgesic efficacy with patient safety.

Opioid-Related Risks

● Respiratory depression

● Sedation

● Hypotension

Risk is increased in elderly patients and those with comorbidities5.

NSAID-Related Risks

● Renal impairment

● Gastrointestinal bleeding

● Cardiovascular events

Careful patient selection is essential22.

Ketamine-Related Effects

● Psychomimetic reactions

● Emergence phenomena

These are typically dose-dependent and less common with low-dose regimens29.

High-Risk Populations

Special caution is required in:

● Elderly patients

● Pregnant individuals

● Patients with chronic disease

Dose adjustments and close monitoring are critical.

High-risk populations require individualized analgesic strategies in emergency settings. Elderly patients are particularly vulnerable to opioid-related sedation, delirium, and respiratory depression, whereas patients with renal impairment may be at increased risk of NSAID-associated nephrotoxicity. Anticoagulated patients require careful assessment before regional anesthesia because of the increased risk of bleeding. In pregnant patients, analgesic selection should balance maternal pain control with fetal safety considerations. Opioid-tolerant individuals and patients with substance use disorder may require alternative or opioid-sparing approaches, including ketamine-based multimodal strategies and careful reassessment.

DISCUSSION

Multimodal pain management represents a significant evolution in emergency medicine, shifting the focus from single-agent therapy to integrated, mechanism-based strategies. The available literature consistently demonstrates that multimodal approaches provide superior analgesic efficacy while reducing opioid requirements and associated adverse effects15, 38. In the ED, where rapid pain control must be achieved without compromising diagnostic accuracy or patient safety, this approach offers clear and practical clinical advantages.

The strength and direct applicability of evidence supporting multimodal analgesia vary across clinical settings. Strong evidence exists for opioid-sparing multimodal strategies in postoperative care, trauma management, geriatric hip fracture, and selected ED populations15, 29, 35. However, in several emergency medicine scenarios, including headache management, renal colic, and mixed-pain presentations, some recommendations are partially extrapolated from perioperative or other non-ED literature. This highlights the ongoing need for ED–specific prospective studies evaluating multimodal analgesic strategies across diverse patient populations and clinical contexts.

Despite this strong evidence base, a substantial gap persists between recommended practices and real-world implementation. Multimodal strategies remain inconsistently applied across EDs, not due to a lack of evidence, but primarily because of system-level and operational barriers. Overcrowding, time constraints, and workflow interruptions frequently delay analgesia, while variability in clinician experience and limited training in advanced techniques—particularly regional anesthesia—further contribute to ongoing oligoanalgesia8, 39. This gap represents a critical and modifiable target for quality improvement in emergency care.

Key Barriers

● ED overcrowding and time constraints

● Lack of standardized protocols

● Limited training in regional anesthesia

● Variability in clinician experience

These factors contribute to delayed treatment, inconsistent pain control, and persistent oligoanalgesia in ED settings8, 39. Importantly, most of these barriers are potentially modifiable, emphasizing the need for system-level interventions.

Proposed Solutions

Protocol-Driven Care

Standardized pain management pathways reduce variability in practice and improve patient outcomes18.

Early Analgesia

(Triage-Based): Initiating analgesia at triage is a practical, evidence-based strategy to minimize delays and improve patient satisfaction.

Education and Training

Structured training programs enhance clinician confidence and facilitate the adoption of multimodal and advanced analgesic techniques, including regional anesthesia.

Opioid Stewardship

Opioid stewardship should be implemented as a balanced, patient-centered strategy that minimizes unnecessary exposure while ensuring adequate pain control, rather than as a restrictive approach40, 41.

Future Directions

● Expansion of ultrasound-guided regional anesthesia

● Increased use of opioid-sparing protocols

● Integration of clinical decision-support systems

These developments are expected to improve the consistency, safety, and effectiveness of pain management in ED settings and help bridge the persistent gap between evidence and clinical practice.

Advanced Clinical Decision-Making Framework in ED Pain Management

Effective pain management in the ED requires a structured, patient-centered approach that integrates clinical context, pharmacology, and risk assessment.

A practical decision-making model in ED pain management includes three key dimensions: pain characteristics, patient factors, and clinical context. Pain characteristics include severity, type (nociceptive, neuropathic, or mixed), and onset. Patient factors encompass age, comorbidities, opioid tolerance, and hemodynamic status. Clinical context includes diagnostic uncertainty, the need for procedural intervention, and resource availability.

Stepwise Multimodal Decision Approach

A stepwise multimodal approach can support clinical decision-making in ED pain management. Initial pain stratification using tools such as the NRS allows classification of pain severity and guides treatment intensity24. Early initiation of multimodal therapy, particularly in moderate-to-severe pain, may improve analgesia while reducing opioid requirements15, 30. Pain should be reassessed within 15-30 minutes to guide treatment escalation or de-escalation, as failure to reassess remains a key contributor to oligoanalgesia6. A practical stepwise framework for ED pain management is outlined in Table 4.

Table 4. Clinical decision framework for ED pain management.

Step

Clinical action

Key principle

1

Pain scoring (NRS)

Rapid stratification

2

Early multimodal therapy

Avoid monotherapy

3

Reassessment (15-30 min)

Dynamic management

4

Escalation or adjustment

Patient-specific

5

Consider regional techniques

Opioid-sparing

Treatment escalation and reassessment should be guided by analgesic response, adverse effects, and patient-specific risk factors.

NRS: Numeric rating scale

Opioid vs Ketamine: A Critical Comparative Analysis

One of the most important paradigm shifts in emergency pain management is the increasing role of ketamine as an alternative or adjunct to opioids.

Mechanistic Differences

● Opioids: μ-receptor agonism → central pain modulation

● Ketamine: NMDA receptor antagonism → reduces central sensitization

This distinction is clinically important, particularly in severe and chronic pain states16.

Clinical Performance

Opioids are potent analgesics and familiar to clinicians, but they carry a risk of respiratory depression and hypotension.

Ketamine preserves airway reflexes, provides hemodynamic stability, and has opioid-sparing effects, although it may cause psychomimetic adverse effects.

Evidence-Based Comparison

Studies have shown that low-dose ketamine provides analgesia comparable to opioids in acute pain, with a lower risk of respiratory compromise29, 30.

Additionally, ketamine is particularly advantageous in:

● Trauma patients

● Hypotensive patients

● Opioid-tolerant individuals

Table 5 compares key clinical differences between opioids and ketamine in ED pain management.

Table 5. Opioid vs. ketamine in ED pain management.

Feature

Opioids

Ketamine

Mechanism

μ-receptor agonist

NMDA antagonist

Respiratory depression

Yes

Minimal

Hemodynamic stability

Variable

Stable

Opioid tolerance

Reduced efficacy

Effective

Typical ED role

Traditional

Increasing

The choice between opioids and ketamine should be individualized according to the clinical context, respiratory risk, hemodynamic status, opioid tolerance, and contraindications.

NMDA: Ketamine acts on N-methyl-D-aspartate

Implementation and Future Perspectives

Despite growing evidence supporting multimodal analgesia, implementation in routine ED practice remains inconsistent. Practical implementation strategies may include standardized multimodal analgesia protocols, triage-based analgesia pathways, nurse-initiated analgesia models, audit-feedback systems, structured ultrasound-guided regional anesthesia training programs, and opioid stewardship initiatives aimed at reducing variability in care and improving patient outcomes. Future developments are likely to include broader adoption of opioid-sparing protocols, ultrasound-guided interventions, personalized analgesic approaches, and digital clinical decision-support systems. Further ED-specific implementation research is needed to optimize integration of multimodal analgesia into routine emergency care.

Study Limitations

This study has several limitations. As a narrative review, it does not follow a formal systematic methodology and may therefore be subject to selection bias. Second, the heterogeneity of included studies limits direct comparison of findings and precludes definitive conclusions. Third, although major guidelines and high-quality studies were incorporated, some relevant evidence may not have been included. Finally, as this review focuses on clinical applicability in emergency settings, variations in local practice and resource availability may affect the generalizability of the findings.

CONCLUSION

Multimodal pain management represents a clinically effective and practical strategy for improving pain control in EDs. By targeting multiple pain pathways simultaneously, this approach enhances analgesic efficacy while reducing opioid exposure and associated adverse effects. Despite strong evidence, implementation remains inconsistent and largely limited by modifiable system-level barriers, including overcrowding, workflow constraints, and variability in clinician training. Addressing these challenges through protocol-driven care, early initiation of analgesia, and structured education may help improve the quality and consistency of pain management. Integrating a structured, patient-centered, and multimodal approach into routine emergency care may help bridge the gap between evidence and practice and support more consistent, high-quality pain management across diverse emergency settings.

Footnotes

Author Contributions: Concept: B.A., F.T.; Design: B.A., F.T.; Literature Search: B.A., F.T.; Analysis and Interpretation: B.A., F.T.; Writing and Revision: B.A., F.T.

Conflict of Interest: The authors declare that they have no conflict of interest related to this study.

Financial Disclosure: The authors declare they have no financial interests.

References

  • 1.Todd KH. Pain assessment and management in the emergency department. Ann Emerg Med. 2007;49:480–2. [Google Scholar]
  • 2.Motov S, Strayer RJ, Hayes BD, et al. Advances in emergency department pain management. Ann Emerg Med. 2023;81:117–29. [Google Scholar]
  • 3.Wilson JE, Pendleton JM. Oligoanalgesia in the emergency department. Am J Emerg Med. 1989;7(6):620–23. doi: 10.1016/0735-6757(89)90286-6. [DOI] [PubMed] [Google Scholar]
  • 4.Sinatra R. Causes and consequences of inadequate management of acute pain. Pain Med. 2010;11(12):1859–71. doi: 10.1111/j.1526-4637.2010.00983.x. [DOI] [PubMed] [Google Scholar]
  • 5.Hwang U, Richardson LD, Harris B, et al. Barriers to effective pain management in older adults in the emergency department. Clin Geriatr Med. 2018;34:395–409. [Google Scholar]
  • 6.Fosnocht DE, Swanson ER, Barton ED, et al. The effect of analgesic administration on diagnostic accuracy in emergency department patients with abdominal pain. Acad Emerg Med. 2005;12:1039–43. [Google Scholar]
  • 7.Friedman BW, Esses D, Solorzano C, et al. Analgesia and diagnostic accuracy in acute abdominal pain. Ann Emerg Med. 2019;73:237–47. [Google Scholar]
  • 8.Pines JM, Hollander JE, Localio AR, et al. The impact of emergency department crowding on patient outcomes. Acad Emerg Med. 2011;18:1325–32. [Google Scholar]
  • 9.Carter D, Sendziuk P, Eliott J, et al. Delays in emergency department care and outcomes. Emerg Med J. 2014;31:94–54. [Google Scholar]
  • 10.Chang AK, Bijur PE, Munjal KG, et al. Effect of opioid prescribing guidelines in acute pain management. JAMA. 2017;318:1661–62. [Google Scholar]
  • 11.Ballantyne JC. The brain on opioids. N Engl J Med. 2016;374:1483–85. [Google Scholar]
  • 12.Todd KH, Deaton C, D’Adamo AP, et al. Ethnicity as a risk factor for inadequate emergency department analgesia. JAMA. 2000;283:477–82. [PubMed] [Google Scholar]
  • 13.Safdar B, Heins A, Homel P, et al. Gender differences in pain management. Acad Emerg Med. 2009;16:414–23. [Google Scholar]
  • 14.Kehlet H, Dahl JB. The value of multimodal analgesia. Anesth Analg. 1993;77(5):1048–56. doi: 10.1213/00000539-199311000-00030. [DOI] [PubMed] [Google Scholar]
  • 15.Chou R, Gordon DB, de Leon-Casasola OA, et al. Management of postoperative pain: a clinical practice guideline. J Pain. 2016;17:131–57. doi: 10.1016/j.jpain.2015.12.008. [DOI] [PubMed] [Google Scholar]
  • 16.Motov S, Rockoff B, Cohen V, et al. Intravenous subdissociative-dose ketamine for analgesia. Ann Emerg Med. 2015;66:222–9. doi: 10.1016/j.annemergmed.2015.03.004. [DOI] [PubMed] [Google Scholar]
  • 17.Herring AA, Ahern TL, Stone MB, et al. Ultrasound-guided regional anesthesia in the emergency department. Ann Emerg Med. 2020;76:321–25. [Google Scholar]
  • 18.American College of Emergency Physicians. Clinical policy: pain management. Irving (TX): American College of Emergency Physicians; 2022. [Google Scholar]
  • 19. [Google Scholar]
  • 20. [Google Scholar]
  • 21.Green SM, Roback MG, Krauss B, et al. Clinical practice of emergency medicine sedation and analgesia. Ann Emerg Med. 2016;67:345–56. [Google Scholar]
  • 22.International Association for the Study of Pain (IASP). IASP terminology. Washington (DC): International Association for the Study of Pain; 2020. [Google Scholar]
  • 23.Moore RA, Derry S, McQuay HJ, et al. NSAIDs for acute pain. Pain. 2015;156:408–13. [Google Scholar]
  • 24.Garra G, Singer AJ, Taira BR, et al. Validation of the wong-baker FACES pain rating scale in pediatric emergency department patients. Acad Emerg Med. 2010;17:50–4. doi: 10.1111/j.1553-2712.2009.00620.x. [DOI] [PubMed] [Google Scholar]
  • 25.Bijur PE, Latimer CT, Gallagher EJ, et al. Validation of the numeric rating scale. Ann Emerg Med. 2003;41:147–153. [Google Scholar]
  • 26.Moore RA, Derry S, Eccleston C, et al. Single-dose oral analgesics for acute postoperative pain in adults. Cochrane Database Syst Rev. 2015; CD008659. doi: 10.1002/14651858.CD008659.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Maund E, McDaid C, Rice S, et al. Paracetamol for acute pain: systematic review. BMJ. 2011;343:d6185. [Google Scholar]
  • 28.Derry S, Moore RA, McQuay HJ, et al. Single dose oral analgesics. Cochrane Database Syst Rev. 2013;CD008659. doi: 10.1002/14651858.CD008659.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Chang AK, Bijur PE, Esses D, et al. Combination analgesics for ED pain. Ann Emerg Med. 2021;77:345–56. doi: 10.1016/j.annemergmed.2020.10.004. [DOI] [PubMed] [Google Scholar]
  • 30.Sin B, Ternas T, Motov S, et al. Ketamine for acute pain. Ann Emerg Med. 2021;78:87–97. [Google Scholar]
  • 31.Motov S, Strayer R, Hayes BD, et al. Ketamine vs morphine for ED pain. Ann Emerg Med. 2017;70:177–85. [Google Scholar]
  • 32.Porter KM, Dayan AD, Dickerson S, et al. Methoxyflurane analgesia. Emerg Med J. 2018;35:120–25. [Google Scholar]
  • 33.Pathan SA, Mitra B, Cameron PA, et al. Methoxyflurane use in ED. Lancet. 2018;391:176–77. [Google Scholar]
  • 34.Buvanendran A, Kroin JS. Multimodal analgesia. Anesth Analg. 2009;109:1547–55. [Google Scholar]
  • 35.Gottlieb M, Holladay D, Peksa GD, et al. Ultrasound-guided nerve blocks. Am J Emerg Med. 2020;38:1195–1200. [Google Scholar]
  • 36.Hsu JR, Mir H, Wally MK, et al. Pain management in trauma. J Orthop Trauma. 2019;33:e158–e182. doi: 10.1097/BOT.0000000000001430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Reed MJ, Rittoo D, Walls A, et al. Fascia iliaca block in ED. Emerg Med J. 2016;33:847–51. [Google Scholar]
  • 38.Friedman BW, Irizarry E, Solorzano C, et al. Headache management. JAMA. 2020;323:693–94. [Google Scholar]
  • 39.Motov S, Mai M, Pushkar I, et al. Multimodal analgesia outcomes. Ann Emerg Med. 2022;79:162–170. [Google Scholar]
  • 40.Fry M, Holdgate A, Nurse J, et al. Delays in analgesia. Australas Emerg Nurs J. 2011;14:7–15. [Google Scholar]
  • 41.Herring AA, Schultz CW, Yang E, et al. Opioid stewardship. Ann Emerg Med. 2021;77:305–14. [Google Scholar]

Articles from Medeniyet Medical Journal are provided here courtesy of Istanbul Medeniyet University

RESOURCES